YD Bio Limited (NASDAQ:YDES – Get Free Report)’s share price gapped down prior to trading on Friday . The stock had previously closed at $12.24, but opened at $11.03. YD Bio shares last traded at $11.67, with a volume of 15,742 shares changing hands.
Wall Street Analyst Weigh In
YDES has been the subject of a number of analyst reports. Wall Street Zen raised YD Bio to a “sell” rating in a research note on Tuesday, November 4th. Weiss Ratings reissued a “sell (d+)” rating on shares of YD Bio in a research note on Monday, December 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.
Read Our Latest Stock Report on YD Bio
YD Bio Trading Up 7.6%
About YD Bio
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
Further Reading
- Five stocks we like better than YD Bio
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
